Application of a small molecule pharmacophore NSC668394 to inhibit ERM phosphorylation in rhabdomyosarcoma cells decreased the cell viability and proliferation in a dose-dependent manner. The gene discussed is ETV5; the disease is rhabdomyosarcoma.